SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Murphy who wrote (2076)1/17/1997 12:09:00 AM
From: BARRY ALLEN   of 2281
 
Shawn.....Why are you rambling all of a sudden? Do YOU really care?
You keep throwing out alot of issues over and over. I will touch on a few.

Yes, we do want Dr. Hirschman to make a statement. He probably will, hopefully soon.

Is Coca-Cola patented? Why can't anyone reproduce it exactly? There are secrets in the formulation of Reticulose such as temperatures that prevent exact duplication.

ADVR did not state anything about an Aids clinic. Rumor. Moot point.

Yes,ADVR was cash poor during the Canadian studies. So? They still are.

They can't do human tests in the U.S. so they have to go offshore like Barbados. Who should review the results?

Should Hirschman work for free? Do you?

Yes, ADVR is diluted. QUIG also used to pay for expenses with stock and options. This is not uncommon with start up companies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext